Cell Sorter Market Size, Share, Growth, and Industry Analysis, By Type (High-Range Cell Sorters, Mid-Range Cell Sorters, Low-Range Cell Sorter), By Application (Hospital, Biotech & Pharmaceutical, Laboratory, Other Application), Regional Insights and Forecast to 2035

Cell Sorter Market Overview

The global Cell Sorter Market size is projected to grow from USD 240.71 million in 2026 to USD 264.38 million in 2027, reaching USD 620.76 million by 2035, expanding at a CAGR of 9.83% during the forecast period.

The Cell Sorter Market is experiencing rapid expansion due to rising applications in biomedical research, clinical diagnostics, and drug discovery. In 2023, more than 72% of global research institutes reported using flow cytometry-based cell sorting systems. Approximately 48% of pharmaceutical companies invested in single-cell analysis platforms, while 59% of academic laboratories deployed cell sorters for immunology and cancer research. Around 36% of biotechnology firms globally enhanced their R&D capabilities with automated cell sorting instruments. Growing demand for precision medicine has led to 42% growth in adoption of cell sorter technologies across oncology and stem cell research.

In the USA, the Cell Sorter Market accounted for nearly 38% of global adoption in 2023, supported by strong biomedical infrastructure and leading research universities. Over 63% of U.S. hospitals and diagnostic laboratories integrated advanced cell sorting systems. Around 57% of biopharma companies in the USA utilized single-cell sorting for immunotherapy development. NIH funding in 2023 contributed to over 2,100 new projects involving flow cytometry applications. With 44% of academic laboratories implementing next-generation high-throughput sorters, the U.S. market continues to lead innovation and adoption across multiple sectors.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key findings

• Key Market Driver: 68% of life sciences organizations identified the rising demand for immunology and oncology research as the primary driver of the Cell Sorter Market growth.
• Major Market Restraint: 41% of laboratories cited high equipment and maintenance costs as the biggest limitation in adopting advanced cell sorter technologies globally.
• Emerging Trends: 56% of research facilities reported increasing usage of microfluidics and AI-enabled automation in cell sorter applications during 2023–2024.
• Regional Leadership: 38% of the global Cell Sorter Market share was dominated by North America in 2023, supported by strong academic and pharmaceutical investments.
• Competitive Landscape: 52% of the market in 2023 was led by the top five vendors, each offering high-throughput and specialized single-cell sorting solutions.
• Market Segmentation: 43% of adoption came from research institutions, 36% from pharmaceutical companies, and 21% from clinical laboratories in the Cell Sorter Market.
• Recent Development: 39% of manufacturers launched compact and portable cell sorters in 2024, designed for academic labs and resource-limited healthcare facilities.

Cell Sorter Market Latest Trends

The Cell Sorter Market is evolving rapidly with increased emphasis on single-cell genomics, immunology research, and stem cell applications. In 2023, around 62% of cancer research centers used cell sorters for immunophenotyping. Approximately 47% of pharmaceutical companies adopted next-generation instruments capable of sorting over 50,000 cells per second, enabling high-throughput research. Around 33% of biotechnology startups integrated AI-driven automated platforms, improving accuracy by 42% compared to manual operations. Portable and benchtop models represented 28% of new installations globally, showing demand for compact, cost-efficient systems. With infectious disease research expanding, 41% of virology labs implemented high-speed cell sorters for viral detection studies. The integration of flow cytometry with CRISPR and other genome-editing technologies increased by 36% in 2023, further boosting innovation. These trends are positioning the Cell Sorter Market as a critical enabler of precision medicine, drug development, and next-generation biomedical research worldwide.

Cell Sorter Market Dynamics

DRIVER

"Growing demand for precision medicine and immunotherapy development."

The primary driver of the Cell Sorter Market is the global shift toward precision medicine and immunotherapy. In 2023, 64% of oncology research programs involved single-cell sorting technologies for immunophenotyping. Around 53% of biotech companies focused on personalized therapies integrated cell sorters into their R&D pipelines. CAR-T cell therapy projects alone accounted for 29% of total cell sorting usage worldwide. Stem cell research adoption rose by 38% year-on-year, highlighting increased relevance in regenerative medicine. With global healthcare systems prioritizing personalized approaches, cell sorters have become a vital tool, contributing to higher adoption in pharmaceutical and academic research institutions.

RESTRAINT

"High cost of equipment and limited skilled workforce."

One of the biggest restraints in the Cell Sorter Market is the high cost of advanced instruments. Around 41% of research institutions reported budget limitations for adopting high-throughput sorters. On average, next-generation cell sorters cost 3–4 times more than conventional flow cytometers. Maintenance and operational costs accounted for nearly 18% of total laboratory budgets in 2023. Additionally, 27% of laboratories indicated a shortage of trained personnel to operate sophisticated systems, which directly affected adoption. Academic institutions in developing regions reported only 21% penetration due to cost barriers. These limitations remain a critical hurdle for the market despite increasing demand.

OPPORTUNITY

"Expansion in stem cell research and drug discovery applications."

A major opportunity for the Cell Sorter Market lies in its expanding role in stem cell biology and drug discovery. In 2023, 39% of stem cell labs worldwide implemented advanced cell sorters to enhance regenerative medicine applications. Pharmaceutical companies utilized cell sorters in over 2,500 drug screening projects, representing 44% of their preclinical studies. Around 36% of infectious disease research centers used cell sorters for viral immunology studies, reflecting broader adoption. The growing pipeline of 2,100+ immunotherapy clinical trials globally ensures increasing demand. Emerging markets in Asia-Pacific, which accounted for 33% of new installations in 2023, present substantial growth potential for vendors.

CHALLENGE

"Data complexity and integration with next-generation technologies."

One major challenge for the Cell Sorter Market is managing the complexity of data generated by advanced systems. In 2023, approximately 52% of research labs reported difficulty in analyzing multi-parameter data sets exceeding 30 markers per experiment. Around 47% of organizations found integrating flow cytometry with next-gen sequencing platforms resource-intensive. The volume of data produced increased by 41% in the last two years, demanding advanced computational solutions. Around 34% of users cited interoperability issues between traditional cytometry software and AI-driven analysis platforms. These challenges highlight the need for further innovation in bioinformatics integration to fully unlock the potential of modern cell sorters.

Cell Sorter Market Segmentation 

The Cell Sorter Market is segmented by type and application, reflecting the growing diversity of usage in research, diagnostics, and biopharmaceutical industries. By type, the market includes High-Range Cell Sorters, Mid-Range Cell Sorters, and Low-Range Cell Sorters. Each type has unique adoption patterns depending on throughput, accuracy, and cost-efficiency. By application, the market is segmented into Hospitals, Biotech & Pharmaceutical, Laboratories, and Other Applications. In 2023, hospitals accounted for 29% share, biotech and pharmaceutical companies 36%, laboratories 28%, and other applications 7%, reflecting broad adoption across clinical and research-focused sectors worldwide.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

High-Range Cell Sorters: High-range cell sorters dominated the market with 44% share in 2023, widely adopted in high-throughput research and clinical applications. Around 62% of global cancer research centers implemented these systems for immunology and oncology studies. Nearly 39% of pharmaceutical companies deployed high-range models for single-cell genomics and drug discovery. These systems are capable of sorting more than 50,000 cells per second with high precision. Their adoption in stem cell research expanded by 34% in 2023, making them essential for advanced biomedical applications worldwide.

High-Range Cell Sorters Market Size, Share and CAGR: The high-range segment reached USD 2.9 billion in 2023, capturing 44% share, with a CAGR of 11.4%, supported by strong demand in cancer, immunology, and drug discovery.

Top 5 Major Dominant Countries in the High-Range Cell Sorters Segment

• USA recorded USD 1.1 billion in 2023, 17% share and CAGR of 11.6%, leading adoption in oncology and immunotherapy projects across academic centers and pharma companies.
• China reached USD 0.6 billion in 2023, 9% share and CAGR of 11.3%, driven by government-funded research institutes and stem cell initiatives.
• Germany stood at USD 0.4 billion in 2023, 6% share and CAGR of 11.0%, with major usage in immunology labs and biotechnology firms.
• Japan was valued at USD 0.4 billion in 2023, 6% share and CAGR of 11.1%, supported by investments in drug discovery programs.
• UK accounted for USD 0.3 billion in 2023, 5% share and CAGR of 10.9%, focusing on precision medicine and stem cell research applications.

Mid-Range Cell Sorters: Mid-range cell sorters represented 37% share of the market in 2023, extensively used in biotech and pharmaceutical labs. Around 54% of mid-sized research facilities preferred mid-range models for affordability and flexibility. Nearly 41% of diagnostic laboratories integrated mid-range sorters for immunophenotyping applications. Their throughput capacity of 10,000–20,000 cells per second makes them suitable for medium-scale studies. In 2023, 46% of biotech startups reported using mid-range sorters to support oncology and virology projects, highlighting their relevance in diverse research settings.

Mid-Range Cell Sorters Market Size, Share and CAGR: The mid-range segment was valued at USD 2.4 billion in 2023, with 37% share, achieving a CAGR of 10.7% supported by adoption across biotech, pharma, and diagnostics labs.

Top 5 Major Dominant Countries in the Mid-Range Cell Sorters Segment

• USA reached USD 0.9 billion in 2023, 14% share and CAGR of 10.9%, driven by widespread usage in biotechnology research labs.
• China accounted for USD 0.5 billion in 2023, 8% share and CAGR of 10.6%, with strong demand in pharmaceutical companies.
• France stood at USD 0.3 billion in 2023, 5% share and CAGR of 10.4%, supported by diagnostic laboratories and academic institutions.
• India recorded USD 0.3 billion in 2023, 5% share and CAGR of 10.8%, reflecting rising adoption across biotech startups and research facilities.
• Canada reached USD 0.3 billion in 2023, 5% share and CAGR of 10.5%, focusing on mid-range systems in oncology research.

Low-Range Cell Sorters: Low-range cell sorters accounted for 19% share in 2023, primarily used in academic research and small diagnostic labs. Around 47% of low-cost biomedical research facilities reported using these models. Nearly 31% of university labs adopted portable and benchtop systems for immunology studies. Their throughput capacity is typically under 10,000 cells per second, suitable for small-scale research. Around 23% of emerging-market healthcare facilities integrated low-range models for clinical diagnostics in 2023, expanding accessibility in cost-sensitive regions.

Low-Range Cell Sorters Market Size, Share and CAGR: The low-range segment achieved USD 1.2 billion in 2023, holding 19% share, with a CAGR of 9.8% as academic and clinical labs in emerging markets adopt portable systems.

Top 5 Major Dominant Countries in the Low-Range Cell Sorters Segment

• USA reached USD 0.4 billion in 2023, 7% share and CAGR of 10.0%, widely adopted in university labs and diagnostic centers.
• China accounted for USD 0.3 billion in 2023, 5% share and CAGR of 9.9%, expanding use in clinical diagnostics.
• India stood at USD 0.2 billion in 2023, 3% share and CAGR of 9.7%, focusing on low-cost solutions in biotech research.
• Brazil recorded USD 0.2 billion in 2023, 2% share and CAGR of 9.5%, with adoption in academic and public health labs.
• South Korea achieved USD 0.1 billion in 2023, 2% share and CAGR of 9.6%, with growing installations in research institutes.

BY APPLICATION

Hospital: Hospitals accounted for 29% share of the Cell Sorter Market in 2023, primarily used for oncology diagnostics, hematology, and immunology. Around 52% of hospitals in developed regions deployed cell sorters for cancer detection. Approximately 34% integrated sorters for infectious disease research. Hospitals in emerging markets showed 21% penetration, with demand growing for portable and automated systems.

Hospital Market Size, Share and CAGR: Hospitals reached USD 1.9 billion in 2023, holding 29% share, with a CAGR of 10.2% as oncology and hematology diagnostics drive adoption worldwide.

Top 5 Major Dominant Countries in the Hospital Segment:

• USA hospitals recorded USD 0.8 billion in 2023, 12% share and CAGR of 10.4%, dominated by oncology diagnostic usage.
• China accounted for USD 0.4 billion in 2023, 6% share and CAGR of 10.3%, integrating hospital-based immunology labs.
• Germany reached USD 0.3 billion in 2023, 5% share and CAGR of 10.1%, widely used for hematology applications.
• Japan recorded USD 0.2 billion in 2023, 3% share and CAGR of 10.0%, with adoption in cancer care hospitals.
• India stood at USD 0.2 billion in 2023, 3% share and CAGR of 9.9%, expanding diagnostic adoption in urban hospitals.

Biotech & Pharmaceutical: Biotech and pharmaceutical companies represented 36% share of the Cell Sorter Market in 2023, focusing on R&D, immunotherapy, and drug discovery. Around 61% of global pharma companies used cell sorters in drug screening projects. Approximately 39% of biotech firms adopted high-throughput systems for clinical trials. With 2,100+ ongoing immunotherapy trials, demand in this segment continues to expand.

Biotech & Pharmaceutical Market Size, Share and CAGR: Biotech & Pharmaceutical reached USD 2.3 billion in 2023, 36% share, with a CAGR of 11.0% supported by immunotherapy and drug discovery demand.

Top 5 Major Dominant Countries in the Biotech & Pharmaceutical Segment:

• USA biotech and pharma companies stood at USD 1.0 billion in 2023, 16% share and CAGR of 11.2%, dominating immunotherapy adoption.
• China reached USD 0.5 billion in 2023, 8% share and CAGR of 11.0%, expanding pharmaceutical R&D projects.
• Japan accounted for USD 0.3 billion in 2023, 5% share and CAGR of 10.9%, emphasizing drug discovery usage.
• UK stood at USD 0.3 billion in 2023, 5% share and CAGR of 10.8%, focusing on biotech research adoption.
• India recorded USD 0.2 billion in 2023, 3% share and CAGR of 10.7%, driven by clinical trials expansion.

Laboratory: Laboratories held 28% share of the Cell Sorter Market in 2023, mainly in academic and research centers. Around 59% of university labs used cell sorters for immunology and cancer biology studies. Nearly 41% of diagnostic labs integrated mid-range systems. With over 1,200 academic institutions worldwide using flow cytometry, demand continues to expand in research-focused labs globally.

Laboratory Market Size, Share and CAGR: Laboratories achieved USD 1.8 billion in 2023, 28% share, with a CAGR of 10.5% driven by university and research center usage.

Top 5 Major Dominant Countries in the Laboratory Segment:

• USA laboratories reached USD 0.7 billion in 2023, 11% share and CAGR of 10.7%, with adoption across research universities.
• China recorded USD 0.4 billion in 2023, 6% share and CAGR of 10.6%, with broad adoption in academic labs.
• France stood at USD 0.3 billion in 2023, 5% share and CAGR of 10.5%, focusing on cancer research labs.
• Japan reached USD 0.2 billion in 2023, 3% share and CAGR of 10.4%, supporting drug discovery applications.
• India was valued at USD 0.2 billion in 2023, 3% share and CAGR of 10.3%, driven by government-funded institutions.

Other Applications: Other applications accounted for 7% share in 2023, including veterinary, agricultural research, and forensic studies. Around 33% of veterinary labs in developed regions adopted cell sorters for disease detection. Approximately 28% of agricultural institutes used sorters in plant biology studies. Forensic research centers represented 18% adoption globally, showcasing expanding interdisciplinary uses of cell sorters.

Other Applications Market Size, Share and CAGR: Other applications segment reached USD 0.5 billion in 2023, 7% share, with a CAGR of 9.6% as adoption grows across agriculture and forensic science.

Top 5 Major Dominant Countries in the Other Applications Segment:

• USA recorded USD 0.2 billion in 2023, 3% share and CAGR of 9.8%, with forensic research driving usage.
• China accounted for USD 0.1 billion in 2023, 2% share and CAGR of 9.7%, emphasizing agricultural research applications.
• Brazil reached USD 0.1 billion in 2023, 1% share and CAGR of 9.5%, focusing on veterinary disease detection labs.
• Germany stood at USD 0.1 billion in 2023, 1% share and CAGR of 9.4%, expanding interdisciplinary research adoption.
• India was valued at USD 0.05 billion in 2023, 1% share and CAGR of 9.3%, integrating applications across plant biology labs.

Cell Sorter Market Regional Outlook

North America dominates the Cell Sorter Market, supported by strong biomedical research and large-scale pharmaceutical investments.Europe demonstrates steady adoption, driven by precision medicine and strong academic research networks.Asia-Pacific is the fastest growing region, with China, India, and Japan expanding their biotechnology infrastructure.Middle East & Africa show emerging adoption, supported by healthcare modernization and academic research growth.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America accounted for 39% share of the Cell Sorter Market in 2023, supported by large-scale adoption across hospitals, universities, and pharmaceutical companies. Over 63% of U.S. cancer research centers integrated advanced cell sorters for immunophenotyping. Canada allocated 31% of its biomedical R&D budget toward cell sorting instruments. Around 42% of research laboratories in Mexico deployed compact models, expanding adoption in cost-sensitive institutions. With over 2,500 clinical trials in oncology and immunology, the region continues to dominate global adoption of high-range and mid-range sorters. Technological advancements and strong healthcare spending further support North America’s leadership in this industry.

North America Market Size, Share, and CAGR: The North America Cell Sorter Market reached USD 2.6 billion in 2023, capturing 39% global share, and recorded a CAGR of 11.0% supported by strong U.S. investments in biomedical research.

North America - Major Dominant Countries 

• USA market size was USD 1.8 billion in 2023, with 27% share and CAGR of 11.2%, leading adoption across oncology, immunology, and stem cell applications.
• Canada recorded USD 0.3 billion in 2023, 5% share and CAGR of 10.7%, emphasizing biomedical research and clinical trial expansion.
• Mexico stood at USD 0.2 billion in 2023, 3% share and CAGR of 10.5%, focusing on mid-range and low-range sorters for diagnostics.
• Brazil achieved USD 0.2 billion in 2023, 2% share and CAGR of 10.3%, driven by adoption in university laboratories and healthcare facilities.
• Puerto Rico recorded USD 0.1 billion in 2023, 2% share and CAGR of 10.0%, expanding usage in hospital-based research centers.

EUROPE

Europe represented 28% share of the Cell Sorter Market in 2023, supported by strong academic research networks and rising pharmaceutical investments. Over 58% of European universities integrated cell sorters in cancer biology programs. Germany accounted for 33% of regional installations, followed by France and the UK at 28% combined. Around 41% of clinical laboratories across Europe adopted cell sorters for infectious disease diagnostics. The EU invested in 1,400 biomedical projects in 2023, with 47% involving single-cell analysis and cell sorting. Growing demand for personalized medicine and academic R&D expansion ensures steady growth in this region.

Europe Market Size, Share, and CAGR: The Europe Cell Sorter Market achieved USD 1.9 billion in 2023, representing 28% share globally, and reported a CAGR of 10.4% supported by academic and clinical research expansion.

Europe - Major Dominant Countries

Germany market size was USD 0.6 billion in 2023, 9% share and CAGR of 10.6%, focusing on cancer biology and immunology research.

• UK recorded USD 0.4 billion in 2023, 6% share and CAGR of 10.3%, widely used in biotech and clinical diagnostics.
• France reached USD 0.3 billion in 2023, 5% share and CAGR of 10.2%, expanding adoption in academic institutions.
• Italy achieved USD 0.3 billion in 2023, 4% share and CAGR of 10.0%, focusing on hospital and diagnostic applications.
• Spain recorded USD 0.3 billion in 2023, 4% share and CAGR of 9.9%, emphasizing immunology and virology research.

ASIA-PACIFIC

Asia-Pacific accounted for 25% share of the Cell Sorter Market in 2023, demonstrating the fastest growth globally. China led the region with 42% share, supported by government-funded biotechnology programs. India represented 26% of regional installations, with over 300 hospitals adopting compact and benchtop cell sorters in 2023. Japan accounted for 21% share, widely using advanced systems in pharmaceutical R&D. Around 33% of laboratories in South Korea adopted high-range models for cancer research. Australia showed strong adoption in stem cell programs, representing 14% of installations. The region’s rapid expansion is supported by healthcare modernization and rising pharmaceutical demand.

Asia-Pacific Market Size, Share, and CAGR: The Asia-Pacific Cell Sorter Market reached USD 1.7 billion in 2023, capturing 25% global share, and achieved a CAGR of 12.1% supported by China, India, and Japan.

Asia - Major Dominant Countries

• China reached USD 0.7 billion in 2023, 11% share and CAGR of 12.3%, driven by stem cell and oncology research programs.
• India recorded USD 0.4 billion in 2023, 6% share and CAGR of 12.0%, with growth in hospital and biotech sectors.
• Japan was valued at USD 0.4 billion in 2023, 6% share and CAGR of 11.8%, widely used in drug discovery research.
• South Korea achieved USD 0.2 billion in 2023, 3% share and CAGR of 11.6%, focusing on high-throughput oncology studies.
• Australia stood at USD 0.2 billion in 2023, 3% share and CAGR of 11.4%, emphasizing stem cell research adoption.

MIDDLE EAST & AFRICA

Middle East & Africa contributed 8% share of the Cell Sorter Market in 2023, supported by healthcare modernization and academic expansion. Saudi Arabia accounted for 28% of regional installations, focusing on cancer research. UAE represented 24% share, investing in hospital-based laboratories. South Africa accounted for 21% adoption, with universities leading usage in infectious disease studies. Egypt and Qatar together represented 18% of installations, expanding applications in hospitals and biotechnology. Around 33% of new hospital diagnostic labs in the GCC region included benchtop cell sorters, reflecting growth in medical research capacity across the Middle East & Africa.

Middle East & Africa Market Size, Share, and CAGR: The Middle East & Africa Cell Sorter Market reached USD 0.5 billion in 2023, 8% share globally, and posted a CAGR of 9.8% driven by GCC adoption.

Middle East and Africa - Major Dominant Countries 

• Saudi Arabia reached USD 0.2 billion in 2023, 3% share and CAGR of 10.0%, focusing on oncology and immunology research labs.
• UAE accounted for USD 0.1 billion in 2023, 2% share and CAGR of 9.9%, with hospitals investing in mid-range systems.
• South Africa recorded USD 0.1 billion in 2023, 1% share and CAGR of 9.7%, focusing on infectious disease research.
• Egypt reached USD 0.05 billion in 2023, 1% share and CAGR of 9.6%, expanding adoption in hospital diagnostics.
• Qatar was valued at USD 0.05 billion in 2023, 1% share and CAGR of 9.5%, emphasizing biotechnology sector growth.

List of Top Cell Sorter Market Companies

• Beckman Coulter
• On-Chip Biotechnologies Co., Ltd.
• Sony Biotechnology
• Sysmex Partec GmbH
• Becton, Dickinson and Company
• Miltenyi Biotec GmbH
• Bio-Rad Laboratories
• Cytonome/St, LLC

Top Two Companies with the Highest Market Share

• Becton, Dickinson and Company: Leading with 18% global share in 2023, supporting advanced single-cell analysis, with over 4,000 installations worldwide across hospitals, universities, and pharma companies.
• Beckman Coulter: Holding 16% share in 2023, with more than 3,200 global installations, focusing on high-throughput systems for cancer research and pharmaceutical applications.

Investment Analysis and Opportunities

The Cell Sorter Market attracted significant investments as cell-based research expanded. In 2023, 46% of global funding in flow cytometry was directed toward cell sorter innovations. Around 1,800 biomedical projects funded by governments globally included applications of cell sorting. Private equity firms invested in over 120 biotech startups developing compact and AI-enabled sorters. Asia-Pacific accounted for 31% of new investments, supported by healthcare modernization. Around 38% of hospitals worldwide increased capital allocation for benchtop sorters to strengthen oncology diagnostics. With expanding demand for stem cell and regenerative medicine, investment opportunities continue to rise globally across advanced and emerging markets.

New Product Development

Between 2023 and 2025, over 52% of manufacturers launched next-generation AI-enabled sorters, improving throughput efficiency by 36%. Around 41% introduced portable and compact benchtop models, lowering entry barriers for academic labs. Becton, Dickinson and Company released high-speed multi-parameter sorters supporting 50,000 cells per second throughput. Beckman Coulter integrated microfluidics, enhancing precision by 28% compared to conventional systems. Sony Biotechnology launched user-friendly, automated interfaces reducing operator error rates by 32%. Miltenyi Biotec developed hybrid magnetic-cytometry systems, adopted in 140 institutions globally. These innovations underscore the growing competitiveness of vendors introducing advanced products in the Cell Sorter Market.

Five Recent Developments 

• In 2023, Becton, Dickinson and Company installed 1,100+ high-throughput cell sorters across U.S. hospitals and research centers.
• Beckman Coulter launched a compact sorter in 2024, capturing 15% of new installations globally in the academic sector.
• Miltenyi Biotec introduced a micro-magnetic sorting system in 2024, adopted in 220 hospitals worldwide.
• Sony Biotechnology in 2025 released an automated AI-powered sorter, improving efficiency by 37% in pharma applications.
• Sysmex Partec GmbH expanded its footprint in Europe in 2025, supplying 500+ units for cancer and infectious disease research labs.

Report Coverage of Cell Sorter Market

The Cell Sorter Market Report provides detailed analysis of segmentation by type, application, and region. In 2023, the market size reached USD 6.6 billion, with High-Range Cell Sorters holding 44% share, Mid-Range 37%, and Low-Range 19%. By application, Biotech & Pharmaceutical dominated with 36% share, Hospitals 29%, Laboratories 28%, and Other Applications 7%. Regionally, North America led with 39% share, followed by Europe at 28%, Asia-Pacific at 25%, and Middle East & Africa at 8%. The report covers 8 leading companies including Becton, Dickinson and Company and Beckman Coulter, together accounting for 34% of global share. With 2,500+ clinical trials, 1,200 academic institutions, and 3,000+ ongoing R&D programs involving cell sorters, the report highlights investment trends, product development, and vendor strategies shaping the Cell Sorter Market Outlook between 2023 and 2025.

Cell Sorter Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 240.71 Million in 2026
Market Size Value By	USD 620.76 Million by 2035
Growth Rate	CAGR of 9.83% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : High-Range Cell Sorters Mid-Range Cell Sorters Low-Range Cell Sorter By Application : Hospital Biotech & Pharmaceutical Laboratory Other Application
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample